ALQ 2.55% $16.06 als limited

ALS Ltd in crosshairs of strategic buyer, fundies ready for...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,122 Posts.
    lightbulb Created with Sketch. 81
    ALS Ltd in crosshairs of strategic buyer, fundies ready for fight
    http://www.copyright link/content/dam/images/g/o/w/9/1/s/image.related.afrArticleLead.620x350.gp8rbu.png/1464746172159.jpg
    Street Talk. Adam Gault
    Fund managers are expected to put up a strong fight for the $2 billion ALS Limited, which is in the cross hairs of a strategic buyer.
    ALS, the chemicals and testing business known as Campbell Brothers until 2012, has been a fundie favourite for years despite a sell-off in its shares.
    Fundies reckon it is a good business battling through the bottom of the cycle. It has been trying to reinvent itself from a mining-related testing company into life sciences in recent years, however the transition is taking some time.
    ALS requested a trading halt on Wednesday morning, in relation to a "potential change of control event".

    It's understood JPMorgan is acting for ALS, while sources said the interest had come from a strategic buyer.
    The shares last closed at $4.05 each - which is well below the $10 mark where they traded only four years ago.
    Fundies suspect ALS is now in the crosshairs of a private equity or trade buyer, given the recent weakness.
    Street Talk flagged interest in the company in January, with sources pointing to a European strategic player and a private equity firm running the ruler over ALS.


    The company's global listed peers include London-listed Intertek, Switzerland's SGS and France's Bureau Veritas.
    ALS's biggest shareholders include Harris Associates and Schroder Investment Management.
    The company has historically been close to JPMorgan and Morgans.
    The halt comes only a day after ALS hosted investors and analysts for an investor day, looking at its life sciences business.


    Read more: http://www.copyright link/street-ta...ready-for-fight-20160601-gp8rbu#ixzz4AI4f9j7P
    Follow us: @FinancialReview on Twitter | financialreview on Facebook
 
watchlist Created with Sketch. Add ALQ (ASX) to my watchlist
(20min delay)
Last
$16.06
Change
0.400(2.55%)
Mkt cap ! $6.624B
Open High Low Value Volume
$15.94 $16.07 $15.85 $2.196M 137.5K

Buyers (Bids)

No. Vol. Price($)
13 663 $16.05
 

Sellers (Offers)

Price($) Vol. No.
$16.06 94 5
View Market Depth
Last trade - 11.19am 22/11/2024 (20 minute delay) ?
ALQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.